Cigarette smoking in Parkinson's disease: Influence on disease progression
Identifieur interne : 003D76 ( Main/Exploration ); précédent : 003D75; suivant : 003D77Cigarette smoking in Parkinson's disease: Influence on disease progression
Auteurs : Guido Alves [Norvège] ; Martin Kurz [Norvège] ; Stein A. Lie [Norvège] ; Jan P. Larsen [Norvège]Source :
- Movement Disorders [ 0885-3185 ] ; 2004-09.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Tabagisme.
English descriptors
- KwdEn :
- Aged, Aged, 80 and over, Cigarette, Cognition Disorders (diagnosis), Cognition Disorders (epidemiology), Cross-Sectional Studies, Disease Progression, Female, Follow-Up Studies, Humans, Male, Nervous system diseases, Nicotine (administration & dosage), Nicotine (pharmacology), Parkinson Disease (diagnosis), Parkinson Disease (epidemiology), Parkinson disease, Parkinson's disease, Prevalence, Prospective Studies, Questionnaires, Severity of Illness Index, Smoking (epidemiology), Substantia Nigra (drug effects), Substantia Nigra (pathology), Tobacco Use Disorder (epidemiology), Tobacco smoking, cigarette smoking, disease progression, mortality.
- MESH :
- chemical , administration & dosage : Nicotine.
- diagnosis : Cognition Disorders, Parkinson Disease.
- drug effects : Substantia Nigra.
- epidemiology : Cognition Disorders, Parkinson Disease, Smoking, Tobacco Use Disorder.
- pathology : Substantia Nigra.
- chemical , pharmacology : Nicotine.
- Aged, Aged, 80 and over, Cross-Sectional Studies, Disease Progression, Female, Follow-Up Studies, Humans, Male, Prevalence, Prospective Studies, Questionnaires, Severity of Illness Index.
Abstract
Previous studies have shown an inverse association between smoking and the prevalence of Parkinson's disease (PD), suggesting that smoking may induce a biological protection against nigral neuronal damage. In 1993, we examined the frequency of cigarette smokers among 239 patients with PD and two control groups. In addition, the progression of parkinsonism and other clinical features were followed prospectively in smoking and nonsmoking PD patients over an 8‐year period. Mortality in the two PD groups was also examined. We found a 50% higher prevalence of smokers in the control groups than in patients with PD. In contrast, during the follow‐up period, there were no significant differences in progression of parkinsonism, cognitive impairment, and mood in smoking and nonsmoking patients with PD. Mortality was also similar in the two groups. The lack of influence on disease progression may indicate that cigarette smoking does not have a major neuroprotective effect in patients with already diagnosed PD. © 2004 Movement Disorder Society
Url:
DOI: 10.1002/mds.20117
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001824
- to stream Istex, to step Curation: 001824
- to stream Istex, to step Checkpoint: 002757
- to stream PubMed, to step Corpus: 003348
- to stream PubMed, to step Curation: 003348
- to stream PubMed, to step Checkpoint: 003524
- to stream Ncbi, to step Merge: 000F40
- to stream Ncbi, to step Curation: 000F40
- to stream Ncbi, to step Checkpoint: 000F40
- to stream Main, to step Merge: 005734
- to stream PascalFrancis, to step Corpus: 002063
- to stream PascalFrancis, to step Curation: 000C58
- to stream PascalFrancis, to step Checkpoint: 002209
- to stream Main, to step Merge: 005A47
- to stream Main, to step Curation: 003D76
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cigarette smoking in Parkinson's disease: Influence on disease progression</title><author><name sortKey="Alves, Guido" sort="Alves, Guido" uniqKey="Alves G" first="Guido" last="Alves">Guido Alves</name></author><author><name sortKey="Kurz, Martin" sort="Kurz, Martin" uniqKey="Kurz M" first="Martin" last="Kurz">Martin Kurz</name></author><author><name sortKey="Lie, Stein A" sort="Lie, Stein A" uniqKey="Lie S" first="Stein A." last="Lie">Stein A. Lie</name></author><author><name sortKey="Larsen, Jan P" sort="Larsen, Jan P" uniqKey="Larsen J" first="Jan P." last="Larsen">Jan P. Larsen</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:95D6C81CB92C202EE0644EA070AD5A4B8E23EC1D</idno><date when="2004" year="2004">2004</date><idno type="doi">10.1002/mds.20117</idno><idno type="url">https://api.istex.fr/document/95D6C81CB92C202EE0644EA070AD5A4B8E23EC1D/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001824</idno><idno type="wicri:Area/Istex/Curation">001824</idno><idno type="wicri:Area/Istex/Checkpoint">002757</idno><idno type="wicri:doubleKey">0885-3185:2004:Alves G:cigarette:smoking:in</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:15372603</idno><idno type="wicri:Area/PubMed/Corpus">003348</idno><idno type="wicri:Area/PubMed/Curation">003348</idno><idno type="wicri:Area/PubMed/Checkpoint">003524</idno><idno type="wicri:Area/Ncbi/Merge">000F40</idno><idno type="wicri:Area/Ncbi/Curation">000F40</idno><idno type="wicri:Area/Ncbi/Checkpoint">000F40</idno><idno type="wicri:doubleKey">0885-3185:2004:Alves G:cigarette:smoking:in</idno><idno type="wicri:Area/Main/Merge">005734</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:04-0549666</idno><idno type="wicri:Area/PascalFrancis/Corpus">002063</idno><idno type="wicri:Area/PascalFrancis/Curation">000C58</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">002209</idno><idno type="wicri:doubleKey">0885-3185:2004:Alves G:cigarette:smoking:in</idno><idno type="wicri:Area/Main/Merge">005A47</idno><idno type="wicri:Area/Main/Curation">003D76</idno><idno type="wicri:Area/Main/Exploration">003D76</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Cigarette smoking in Parkinson's disease: Influence on disease progression</title><author><name sortKey="Alves, Guido" sort="Alves, Guido" uniqKey="Alves G" first="Guido" last="Alves">Guido Alves</name><affiliation wicri:level="1"><country xml:lang="fr">Norvège</country><wicri:regionArea>Department of Neurology, Central Hospital of Rogaland, Stavanger</wicri:regionArea><wicri:noRegion>Stavanger</wicri:noRegion></affiliation></author><author><name sortKey="Kurz, Martin" sort="Kurz, Martin" uniqKey="Kurz M" first="Martin" last="Kurz">Martin Kurz</name><affiliation wicri:level="1"><country xml:lang="fr">Norvège</country><wicri:regionArea>Department of Neurology, Central Hospital of Rogaland, Stavanger</wicri:regionArea><wicri:noRegion>Stavanger</wicri:noRegion></affiliation></author><author><name sortKey="Lie, Stein A" sort="Lie, Stein A" uniqKey="Lie S" first="Stein A." last="Lie">Stein A. Lie</name><affiliation wicri:level="1"><country xml:lang="fr">Norvège</country><wicri:regionArea>Section for Medical Statistics, Department of Public Health and Primary Health Care, University of Bergen</wicri:regionArea><wicri:noRegion>University of Bergen</wicri:noRegion></affiliation></author><author><name sortKey="Larsen, Jan P" sort="Larsen, Jan P" uniqKey="Larsen J" first="Jan P." last="Larsen">Jan P. Larsen</name><affiliation wicri:level="1"><country xml:lang="fr">Norvège</country><wicri:regionArea>Department of Neurology, Central Hospital of Rogaland, Stavanger</wicri:regionArea><wicri:noRegion>Stavanger</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2004-09">2004-09</date><biblScope unit="vol">19</biblScope><biblScope unit="issue">9</biblScope><biblScope unit="page" from="1087">1087</biblScope><biblScope unit="page" to="1092">1092</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">95D6C81CB92C202EE0644EA070AD5A4B8E23EC1D</idno><idno type="DOI">10.1002/mds.20117</idno><idno type="ArticleID">MDS20117</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Cigarette</term><term>Cognition Disorders (diagnosis)</term><term>Cognition Disorders (epidemiology)</term><term>Cross-Sectional Studies</term><term>Disease Progression</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Male</term><term>Nervous system diseases</term><term>Nicotine (administration & dosage)</term><term>Nicotine (pharmacology)</term><term>Parkinson Disease (diagnosis)</term><term>Parkinson Disease (epidemiology)</term><term>Parkinson disease</term><term>Parkinson's disease</term><term>Prevalence</term><term>Prospective Studies</term><term>Questionnaires</term><term>Severity of Illness Index</term><term>Smoking (epidemiology)</term><term>Substantia Nigra (drug effects)</term><term>Substantia Nigra (pathology)</term><term>Tobacco Use Disorder (epidemiology)</term><term>Tobacco smoking</term><term>cigarette smoking</term><term>disease progression</term><term>mortality</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Nicotine</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Cognition Disorders</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Substantia Nigra</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Cognition Disorders</term><term>Parkinson Disease</term><term>Smoking</term><term>Tobacco Use Disorder</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Substantia Nigra</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Nicotine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Cross-Sectional Studies</term><term>Disease Progression</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Male</term><term>Prevalence</term><term>Prospective Studies</term><term>Questionnaires</term><term>Severity of Illness Index</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Cigarette</term><term>Parkinson maladie</term><term>Système nerveux pathologie</term><term>Tabagisme</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Tabagisme</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Previous studies have shown an inverse association between smoking and the prevalence of Parkinson's disease (PD), suggesting that smoking may induce a biological protection against nigral neuronal damage. In 1993, we examined the frequency of cigarette smokers among 239 patients with PD and two control groups. In addition, the progression of parkinsonism and other clinical features were followed prospectively in smoking and nonsmoking PD patients over an 8‐year period. Mortality in the two PD groups was also examined. We found a 50% higher prevalence of smokers in the control groups than in patients with PD. In contrast, during the follow‐up period, there were no significant differences in progression of parkinsonism, cognitive impairment, and mood in smoking and nonsmoking patients with PD. Mortality was also similar in the two groups. The lack of influence on disease progression may indicate that cigarette smoking does not have a major neuroprotective effect in patients with already diagnosed PD. © 2004 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>Norvège</li></country></list><tree><country name="Norvège"><noRegion><name sortKey="Alves, Guido" sort="Alves, Guido" uniqKey="Alves G" first="Guido" last="Alves">Guido Alves</name></noRegion><name sortKey="Kurz, Martin" sort="Kurz, Martin" uniqKey="Kurz M" first="Martin" last="Kurz">Martin Kurz</name><name sortKey="Larsen, Jan P" sort="Larsen, Jan P" uniqKey="Larsen J" first="Jan P." last="Larsen">Jan P. Larsen</name><name sortKey="Lie, Stein A" sort="Lie, Stein A" uniqKey="Lie S" first="Stein A." last="Lie">Stein A. Lie</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003D76 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003D76 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:95D6C81CB92C202EE0644EA070AD5A4B8E23EC1D
|texte= Cigarette smoking in Parkinson's disease: Influence on disease progression
}}
| This area was generated with Dilib version V0.6.23. |  |